LIFECORE BIOMEDICAL, INC. Non Peo Neo Avg Comp Actually Paid Amt
LIFECORE BIOMEDICAL, INC. (LFCR) reported Non Peo Neo Avg Comp Actually Paid Amt of $908.23 thousand for the 7-month period ending 2025-12-31, per its DEF 14A filed 2026-04-24.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:NonPeoNeoAvgCompActuallyPaidAmt · last filed 2026-04-24
| Period end | Non Peo Neo Avg Comp Actually Paid Amt 7 month | Non Peo Neo Avg Comp Actually Paid Amt 12 month |
|---|---|---|
| 2025-12-31 | $908.23K DEF 14A · filed 2026-04-24 | |
| 2025-05-25 | $3.95M DEF 14A · filed 2026-04-24 | |
| 2024-05-26 | $950.83K DEF 14A · filed 2026-04-24 | |
| 2023-05-28 | $777.24K DEF 14A · filed 2026-04-24 | |
| 2022-05-29 | $451.47K DEF 14A · filed 2026-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |